Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

35.40p
   
  • Change Today:
      0.25p
  • 52 Week High: 70.00
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 1,314,613
  • Market Cap: £191.30m
  • RiskGrade: 119

Tuesday broker round-up

By Caoimhe Toman

Date: Tuesday 17 Apr 2018

LONDON (ShareCast) - (ShareCast News) - Sage Group: JP Morgan downgrades to neutral with a target price of 670p.
Learning Technologies Group: Berenberg reiterates buy with a target price of 105p.

B&M: Deutsche Bank reiterates buy.

Shire: Deutsche Bank reiterates buy.

Legal & General: HSBC reiterates buy with a target price of 315p.

Imperial Brands: JP Morgan reiterates neutral with a target price of 2,700p.

St James place: JP Morgan reiterates overweight with a target price of 1,329p.

JD Sports: Shore Capital Markets reiterates buy.

Tate & Lyle: Shore Capital Markets reiterates hold.

Breedon: Shore Capital Markets reiterates buy.

Ashmore Group: Numis upgrades to hold with a target price of 386p.

Alliance Pharma: Numis reiterates buy with a target price of 88p.

Majestic Wine: Canaccord reiterates sell with a target price of 340p.

GVC Holdings: Berenberg reiterates buy with a target price of 1,200p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 35.40p
Change Today 0.25p
% Change 0.71 %
52 Week High 70.00
52 Week Low 29.35
Volume 1,314,613
Shares Issued 540.40m
Market Cap £191.30m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.33% above the market average92.33% above the market average92.33% above the market average92.33% above the market average92.33% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
68.62% below the market average68.62% below the market average68.62% below the market average68.62% below the market average68.62% below the market average
14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average
Income
32.16% above the market average32.16% above the market average32.16% above the market average32.16% above the market average32.16% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
89.29% below the market average89.29% below the market average89.29% below the market average89.29% below the market average89.29% below the market average
88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 17-May-2024

Time Volume / Share Price
16:35 68,902 @ 35.40p
16:35 618 @ 35.40p
16:35 491 @ 35.40p
16:35 2,455 @ 35.40p
16:35 2,462 @ 35.40p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page